Position in RYTM
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$111
-$149 QoQ
Shares Held
1
-66.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#298
of 299 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DiNuzzo Private Wealth, Inc. holds $53,387 across 28 Biotechnology names. RYTM ranks #25 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27 | $13,411 | |
| 2 | TLSA |
Tiziana Life Sciences Ltd
|
5,000 | $6,400 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6 | $3,741 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
13 | $3,132 | |
| 5 | INCY |
Incyte Corp
|
25 | $2,834 | |
| 6 | EXEL |
Exelixis, Inc.
|
52 | $2,829 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8 | $2,408 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
67 | $2,371 |
All Filings in RYTM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $111 | 1 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $260 | 3 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $321 | 3 | Shares | Sole | 2026-01-16 | |
| No filing history on record for this holder in this stock. | ||||||